2020
DOI: 10.4103/ijpm.ijpm_433_19
|View full text |Cite
|
Sign up to set email alerts
|

Diagnosis of the leukemic phase of ALK-positive anaplastic large cell lymphoma by immunohistochemistry on cell block prepared from peripheral blood buffy coat

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 12 publications
0
3
0
Order By: Relevance
“…To the best of our knowledge, only one case report has been published describing the diagnosis of SC-ALCL aided by CB prepared from peripheral blood, but that case also included a cutaneous nodule biopsy. 7 Ours is the first report of a case to be diagnosed using only peripheral blood. Immunostaining with a CB of peripheral blood enabled confirmation of ALK-and CD30-positivity in large cells, which are difficult to detect with flow cytometry.…”
Section: Discussionmentioning
confidence: 93%
See 1 more Smart Citation
“…To the best of our knowledge, only one case report has been published describing the diagnosis of SC-ALCL aided by CB prepared from peripheral blood, but that case also included a cutaneous nodule biopsy. 7 Ours is the first report of a case to be diagnosed using only peripheral blood. Immunostaining with a CB of peripheral blood enabled confirmation of ALK-and CD30-positivity in large cells, which are difficult to detect with flow cytometry.…”
Section: Discussionmentioning
confidence: 93%
“…To the best of our knowledge, only one case report has been published describing the diagnosis of SC‐ALCL aided by CB prepared from peripheral blood, but that case also included a cutaneous nodule biopsy 7 . Ours is the first report of a case to be diagnosed using only peripheral blood.…”
Section: Discussionmentioning
confidence: 96%
“…Although ALK-positive ALCL cases have a relatively good outcome, the small-cell leukemic variant is -irrespective of ALK-translocation status- an aggressive disease. A total of 35 cases of leukaemic, small cell variant of ALK-positive ALCLs have been previously reported [ 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 ] ( Table 1 ) with limited follow-up time (from 1 to 63 months) in the surviving patients. All evidence points to an aggressive disease with a median overall survival of 12 months and a high tendency for central nervous system recurrences.…”
Section: Case Reportmentioning
confidence: 99%